Enrica Menditto Selected Research

Polypharmacy

1/2019	Patterns of multimorbidity and polypharmacy in young and adult population: Systematic associations among chronic diseases and drugs using factor analysis.
9/2018	Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe.
1/2018	A case study of polypharmacy management in nine European countries: Implications for change management and implementation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Enrica Menditto Research Topics

Disease

6	COVID-19 03/2022 - 01/2021
3	Drug-Related Side Effects and Adverse Reactions 01/2022 - 01/2018
3	Chronic Disease (Chronic Diseases) 01/2020 - 09/2018
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2011
3	Rhinitis 11/2019 - 01/2019
2	Infections 10/2021 - 01/2021
2	Asthma (Bronchial Asthma) 11/2019 - 01/2019
2	Pain (Aches) 01/2019 - 01/2015
2	Heart Failure 01/2019 - 12/2005
1	Gastroesophageal Reflux (GERD) 01/2022
1	Virus Diseases (Viral Diseases) 10/2021
1	Venous Thromboembolism 10/2021
1	Migraine Disorders (Migraine) 11/2020
1	Allergic Rhinitis 01/2020
1	Chronic Renal Insufficiency 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2017
1	Osteoporosis 05/2016
1	Schizophrenia (Dementia Praecox) 11/2015
1	Diabetes Complications 01/2013
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2011
1	Stomach Neoplasms (Stomach Cancer) 03/2009
1	Coronary Artery Disease (Coronary Atherosclerosis) 08/2006

Drug/Important Bio-Agent (IBA)

10	Pharmaceutical PreparationsIBA 11/2021 - 03/2009
2	Antipsychotic Agents (Antipsychotics)IBA 11/2021 - 11/2015
2	AllergensIBA 01/2020 - 11/2019
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 01/2015
1	VaccinesIBA 03/2022
1	Proton Pump InhibitorsIBA 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 11/2021
1	Vasodilator Agents (Vasodilators)IBA 11/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2021
1	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 11/2021
1	PotassiumIBA 11/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2021
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 11/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 10/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Guanosine Diphosphate (GDP)IBA 01/2021
1	Tryptamines (Triptans)IBA 11/2020
1	Pizotyline (BC 105)IBA 11/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018
1	Biological ProductsIBA 01/2017
1	Olanzapine (Zyprexa)FDA Link 11/2015
1	Human Regular Insulin (Humulin)IBA 01/2013
1	Short-Acting InsulinIBA 01/2013
1	Angiotensin IIIBA 01/2011
1	Losartan (Cozaar)FDA LinkGeneric 01/2011
1	Cisplatin (Platino)FDA LinkGeneric 03/2009
1	Capecitabine (Xeloda)FDA Link 03/2009
1	Fluorouracil (Carac)FDA LinkGeneric 03/2009
1	Amlodipine (Norvasc)FDA LinkGeneric 08/2006
1	Bisoprolol (Concor)FDA LinkGeneric 12/2005

Therapy/Procedure

8	Therapeutics 01/2022 - 12/2005
3	Polypharmacy 01/2019 - 01/2018
2	Drug Therapy (Chemotherapy) 01/2020 - 11/2019
1	Personal Protective Equipment 01/2022
1	Inappropriate Prescribing 01/2022
1	Drug Prescriptions 01/2020
1	Self Medication 01/2019
1	Activities of Daily Living (ADL) 09/2018
1	Biological Therapy 01/2017